JANTOVEN Side Effects

7018490-7 | International Normalised Ratio Increased
on Sep 13, 2010 Female patient from UNITED STATES , 76 years of age, was treated with Jantoven (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased. Jantoven dosage: 1 In 1 D, Oral. During the same period patient was treated with PROTONIX (View Protonix Review and Protonix Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), XALATAN (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

6957000-7 | Haemorrhage, International Normalised Ratio Increased
Patient was taking Jantoven (View Usage). Patient had the following side effects: haemorrhage, international normalised ratio increased on Aug 27, 2010 from UNITED STATES Additional patient health information: Female patient , 65 years of age, weighting 168.0 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?), open reduction of fracture, thrombosis prophylaxis and. Jantoven dosage: 1 Tablet Daily Po. During the same period patient was treated with LOVENOX (40mg Twice Daily Sq) (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6454269-2 | Activated Partial Thromboplastin Time Prolonged, Sarcoidosis, Skin Haemorrhage
Adverse event was reported on Nov 04, 2009 by a Female patient taking Jantoven (View Usage) (Dosage: 1 In 1 D, Oral) was diagnosed with thrombosis prophylaxis and. Location: UNITED STATES , 49 years of age, weighting 186.4 lb, After Jantoven was administered, patient had the following side effects: activated partial thromboplastin time prolonged, sarcoidosis, skin haemorrhage. During the same period patient was treated with ENOXAPARIN SODIUM (80 Mg Once) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), MAXZIDE (View Maxzide Review and Maxzide Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), CIMETIDINE (View Cimetidine Review and Cimetidine Label ), KLOR CON (View Klor-con Review and Klor-con Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

6439219-7 | Product Label Issue
on Nov 11, 2009 Female patient from UNITED STATES , 60 years of age, weighting 154.3 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Jantoven (View Usage). Patient experienced the following unwanted or unexpected effects: product label issue. Jantoven dosage: 5 Mg Daily Po Years.


6425127-4 | Haemoptysis
on Jun 10, 2009 Male patient from UNITED STATES , 81 years of age, weighting 183.0 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?), chronic obstructive pulmonary disease and was treated with Jantoven (View Usage). Patient had the following side effects: haemoptysis. Jantoven dosage: See Image. During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ). Patient was hospitalized.

6356565-6 | Product Substitution Issue
Patient was taking Jantoven (View Usage). After Jantoven was administered, patient had the following side effects: product substitution issue on Sep 10, 2009 from UNITED STATES Additional patient health information: Male patient , 71 years of age, weighting 220.0 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Jantoven dosage: 10 Mg 1x Po. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6136605-X | Abdominal Pain, Blood Urine Present, Incorrect Dose Administered, Inflammation, International Normalised Ratio Increased, Renal Disorder
Adverse event was reported on Mar 10, 2009 by a Female patient taking Jantoven (View Usage) (Dosage: 20mg, Qd, Po) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED STATES , 63 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood urine present, incorrect dose administered, inflammation, international normalised ratio increased, renal disorder. During the same period patient was treated with ESTRADIOL (View Estradiol Review and Estradiol Label ), MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ), WELLBUTRIN SR (View Wellbutrin Sr Review and Wellbutrin Sr Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), TIKOSYN (View Tikosyn Review and Tikosyn Label ). Patient was hospitalized.

5927348-3 | Haemorrhage, International Normalised Ratio Increased, Nephrolithiasis
on Oct 08, 2008 Female patient from UNITED STATES , 85 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Jantoven (View Usage). Patient had the following side effects: haemorrhage, international normalised ratio increased, nephrolithiasis. Jantoven dosage: 2.5mg, Qd, Po. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

5911643-8 | Diarrhoea, International Normalised Ratio Decreased, International Normalised Ratio Increased, Lower Gastrointestinal Haemorrhage, Rectal Haemorrhage
on Sep 27, 2008 Male patient from UNITED STATES , 86 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Jantoven (View Usage). After Jantoven was administered, patient had the following side effects: diarrhoea, international normalised ratio decreased, international normalised ratio increased, lower gastrointestinal haemorrhage, rectal haemorrhage. Jantoven dosage: Refer To Narrative In B.5. During the same period patient was treated with CARDIZEM CD (View Cardizem Cd Review and Cardizem Cd Label ), FLOMAX (View Flomax Review and Flomax Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LASIX (View Lasix Review and Lasix Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), FLONASE (View Flonase Review and Flonase Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

5894204-9 | International Normalised Ratio Increased, Prothrombin Time Prolonged, Skin Laceration
Patient was taking Jantoven (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased, prothrombin time prolonged, skin laceration on Sep 15, 2008 from UNITED STATES Additional patient health information: Female patient , 94 years of age, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Jantoven dosage: . During the same period patient was treated with TIMOLOL (View Timolol Review and Timolol Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), XALATAN (View Xalatan Review and Xalatan Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ). Patient was hospitalized.

5887870-5 | International Normalised Ratio Increased, Prothrombin Time Prolonged
Adverse event was reported on Aug 27, 2008 by a Female patient taking Jantoven (View Usage) (Dosage: 5 Mg, Qd, Po) was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Location: UNITED STATES , 94 years of age, Patient had the following side effects: international normalised ratio increased, prothrombin time prolonged. During the same period patient was treated with TIMOLOL (View Timolol Review and Timolol Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), XALATAN (View Xalatan Review and Xalatan Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ). Patient was hospitalized.

5887869-9 | International Normalised Ratio Increased, Prothrombin Time Prolonged
on Aug 27, 2008 Female patient from UNITED STATES , 79 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Jantoven (View Usage). After Jantoven was administered, patient had the following side effects: international normalised ratio increased, prothrombin time prolonged. Jantoven dosage: 4.5 Mg, Qd, Po. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), PERCOCET (View Percocet Review and Percocet Label ), K DUR (View K-dur Review and K-dur Label ).

5729065-1 | Amyloidosis, Bone Marrow Disorder, Cough, Feeling Abnormal, Onychalgia, Pain, Pain In Extremity, Prothrombin Level Abnormal, Spinal Operation
on Apr 16, 2008 Male patient from UNITED STATES , 71 years of age, was diagnosed with transient ischaemic attack and was treated with Jantoven (View Usage). Patient experienced the following unwanted or unexpected effects: amyloidosis, bone marrow disorder, cough, feeling abnormal, onychalgia, pain (What is pain?), pain in extremity, prothrombin level abnormal, spinal operation. Jantoven dosage: 5 Mg, Qd, Po. During the same period patient was treated with WARFARIN SODIUM (Po) (View Warfarin Sodium Review and Warfarin Sodium Label ), NORCO (View Norco Review and Norco Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), FLOMAX (View Flomax Review and Flomax Label ), PREVACID (View Prevacid Review and Prevacid Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

5717180-8 | Abdominal Distension, Abdominal Pain, Anorexia, Flatulence, Nausea, Oedema Peripheral
Patient was taking Jantoven (View Usage). Patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), anorexia, flatulence, nausea (What is nausea?), oedema peripheral on Apr 02, 2008 from UNITED STATES Additional patient health information: Female patient , 85 years of age, was diagnosed with cardiac valve prosthesis user and. Jantoven dosage: See Image. During the same period patient was treated with IMDUR (View Imdur Review and Imdur Label ), VASOTEC (View Vasotec Review and Vasotec Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), PROTONIX (View Protonix Review and Protonix Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ).

5688083-2 | Bone Neoplasm Malignant, Cough, Pain, Post Procedural Complication, Prothrombin Time Abnormal, Renal Disorder, Renal Failure, Weight Decreased
Adverse event was reported on Mar 11, 2008 by a Male patient taking Jantoven (View Usage) (Dosage: 5 Mg, Qd, Po) was diagnosed with transient ischaemic attack and. Location: UNITED STATES , 71 years of age, After Jantoven was administered, patient had the following side effects: bone neoplasm malignant, cough, pain (What is pain?), post procedural complication, prothrombin time abnormal, renal disorder, renal failure, weight decreased. During the same period patient was treated with WARFARIN SODIUM (Po) (View Warfarin Sodium Review and Warfarin Sodium Label ), NORCO (View Norco Review and Norco Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), FLOMAX (View Flomax Review and Flomax Label ), PREVACID (View Prevacid Review and Prevacid Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

5585605-7 | Gangrene, Skin Necrosis
on Jan 02, 2007 Female patient from UNITED STATES , 54 years of age, weighting 350.5 lb, was diagnosed with pulmonary embolism (What is pulmonary embolism?) and was treated with Jantoven (View Usage). Patient experienced the following unwanted or unexpected effects: gangrene, skin necrosis. Jantoven dosage: 2 Mg, One Dose, Po. During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), BENADRYL (View Benadryl Review and Benadryl Label ).

5507152-0 | Cerebrovascular Accident, International Normalised Ratio Decreased
on Oct 24, 2007 Male patient from UNITED STATES , 78 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Jantoven (View Usage). Patient had the following side effects: cerebrovascular accident, international normalised ratio decreased. Jantoven dosage: . During the same period patient was treated with WARFARIN SODIUM (Po) (View Warfarin Sodium Review and Warfarin Sodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ACIPHEX (View Aciphex Review and Aciphex Label ). Patient was hospitalized.

5494144-3 | Deep Vein Thrombosis, International Normalised Ratio Decreased, Laboratory Test Interference, Venous Thrombosis Limb
Patient was taking Jantoven (View Usage). After Jantoven was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), international normalised ratio decreased, laboratory test interference, venous thrombosis limb on Oct 02, 2007 from UNITED STATES Additional patient health information: Female patient , 55 years of age, was diagnosed with protein c deficiency and. Jantoven dosage: 5 Mg Alternating With 7.5 Mg, Qd, Po. During the same period patient was treated with WARFARIN SODIUM (Po) (View Warfarin Sodium Review and Warfarin Sodium Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), BIOTIN (View Biotin Review and Biotin Label ). Patient was hospitalized.

5384957-0 | International Normalised Ratio Decreased
Adverse event was reported on Jun 19, 2007 by a Male patient taking Jantoven (View Usage) (Dosage: 20 Mg, Qd, Po) . Location: UNITED STATES , 24 years of age, Patient experienced the following unwanted or unexpected effects: international normalised ratio decreased. During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), PEPCID (View Pepcid Review and Pepcid Label ), VICODIN (View Vicodin Review and Vicodin Label ), NOVOLIN R (View Novolin R Review and Novolin R Label ), PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

5320122-0 | Asthenia, Dysstasia, Insomnia, International Normalised Ratio Increased, Muscle Rigidity, Pain, Restlessness
on Apr 09, 2007 Male patient from UNITED STATES , 58 years of age, was diagnosed with thrombosis, parkinson's disease (What is parkinson's disease?) and was treated with Jantoven (View Usage). Patient had the following side effects: asthenia, dysstasia, insomnia, international normalised ratio increased, muscle rigidity, pain (What is pain?), restlessness. Jantoven dosage: See Image. During the same period patient was treated with WARFARIN SODIUM (7.5 Mg, Qd, Po) (View Warfarin Sodium Review and Warfarin Sodium Label ), COMTAN (200 Mg, Qid, Po) (View Comtan Review and Comtan Label ), TRIHEXYPHENIDYL 2 MG (MFR UNK) (2 Mg, Bid, Po) (View Trihexyphenidyl 2 Mg (mfr Unk) Review and Trihexyphenidyl 2 Mg (mfr Unk) Label ), SINEMET (6.5 Tabs, Qd, Po) (View Sinemet Review and Sinemet Label ), SINEMET CR (2 Tabs, Qd, Po) (View Sinemet Cr Review and Sinemet Cr Label ), AMBIEN (View Ambien Review and Ambien Label ), REQUIP (View Requip Review and Requip Label ), CALCIUM CHLORIDE (View Calcium Chloride Review and Calcium Chloride Label ).

5232745-8 | Abdominal Pain Upper, Asthenia, Cardiac Arrest, Cerebral Haemorrhage, Faeces Discoloured, Hallucination, International Normalised Ratio Increased, Post Procedural Haemorrhage
on Feb 06, 2007 Female patient from UNITED STATES , 82 years of age, weighting 145.0 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Jantoven (View Usage). After Jantoven was administered, patient had the following side effects: abdominal pain upper, asthenia, cardiac arrest (What is cardiac arrest?), cerebral haemorrhage, faeces discoloured, hallucination, international normalised ratio increased, post procedural haemorrhage. Jantoven dosage: 2.5mg 1x D Oral.

5228798-3 | Headache, Prothrombin Time Abnormal, Subdural Haematoma
Patient was taking Jantoven (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), prothrombin time abnormal, subdural haematoma on Jan 18, 2007 from UNITED STATES Additional patient health information: Male patient , 78 years of age, . Jantoven dosage: Po. Patient was hospitalized.

5199726-4 | Gangrene, Skin Discolouration, Skin Necrosis
Adverse event was reported on Jan 02, 2007 by a Female patient taking Jantoven (View Usage) (Dosage: Daily Po) was diagnosed with pulmonary embolism (What is pulmonary embolism?) and. Location: UNITED STATES , 54 years of age, weighting 224.9 lb, Patient had the following side effects: gangrene, skin discolouration, skin necrosis.

5162385-0 | International Normalised Ratio Abnormal, Intra-abdominal Haemorrhage, Prothrombin Time Abnormal
on Nov 29, 2006 Female patient from UNITED STATES , 27 years of age, weighting 220.0 lb, was diagnosed with antiphospholipid syndrome and was treated with Jantoven (View Usage). After Jantoven was administered, patient had the following side effects: international normalised ratio abnormal, intra-abdominal haemorrhage, prothrombin time abnormal. Jantoven dosage: 10 Mg M-w-f Po ; 7.5 Mg Sa-su-tu-th Po. Patient was hospitalized.

5143985-0 | Urticaria
on Nov 02, 2006 Female patient from UNITED STATES , weighting 203.0 lb, was diagnosed with embolism and was treated with Jantoven (View Usage). Patient experienced the following unwanted or unexpected effects: urticaria. Jantoven dosage: 6 Mg Once A Day Po.

4878637-5 | International Normalised Ratio Increased
Patient was taking Jantoven (View Usage). Patient had the following side effects: international normalised ratio increased on Aug 20, 2004 from UNITED STATES Additional patient health information: Male patient , weighting 200.0 lb, . Jantoven dosage: 5 Mg Qd Po. During the same period patient was treated with LIPITOR (CONTIN) (View Lipitor (contin) Review and Lipitor (contin) Label ), PLAVIX (CONTIN) (View Plavix (contin) Review and Plavix (contin) Label ), ACTOS (CONTIN) (View Actos (contin) Review and Actos (contin) Label ), MONOPRIL (CONTIN) (View Monopril (contin) Review and Monopril (contin) Label ), NORVASC (CONTIN) (View Norvasc (contin) Review and Norvasc (contin) Label ), TOPROL (CONTIN) (View Toprol (contin) Review and Toprol (contin) Label ). Patient was hospitalized.

4878635-1 | Chest Pain
Adverse event was reported on Feb 17, 2005 by a Female patient taking Jantoven (View Usage) (Dosage: 5 Mg Qd Po) was diagnosed with thrombosis and. Location: UNITED STATES , 44 years of age, After Jantoven was administered, patient had the following side effects: chest pain (What is chest pain?). Patient was hospitalized.

4878633-8 | International Normalised Ratio Increased
on Apr 18, 2005 Female patient from UNITED STATES , 90 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Jantoven (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased. Jantoven dosage: 4 Mg Qd Po. During the same period patient was treated with WARFARIN SODIUM (4.5 Mg Qd Po) (View Warfarin Sodium Review and Warfarin Sodium Label ), REQUIP (CONTIN) (View Requip (contin) Review and Requip (contin) Label ), SINEMET (CONTIN) (View Sinemet (contin) Review and Sinemet (contin) Label ), WELLBUTRIN (CONTIN) (View Wellbutrin (contin) Review and Wellbutrin (contin) Label ). Patient was hospitalized.

4839586-1 | Feeling Hot, Oedema Peripheral, Pain In Extremity
on Nov 28, 2005 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and was treated with Jantoven (View Usage). Patient had the following side effects: feeling hot, oedema peripheral, pain in extremity. Jantoven dosage: 5mg 4 Days Per Week, 2.5 Mg 3 Days Per Week Po. During the same period patient was treated with UNIRETIC (View Uniretic Review and Uniretic Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), DARVOCET N 100 (View Darvocet-n 100 Review and Darvocet-n 100 Label ).

4828268-8 | International Normalised Ratio Increased
Patient was taking Jantoven (View Usage). After Jantoven was administered, patient had the following side effects: international normalised ratio increased on Nov 14, 2005 from UNITED STATES Additional patient health information: Male patient , weighting 160.0 lb, was diagnosed with heart valve replacement and. Jantoven dosage: 2.5 Mg On 3 Days/wk Po 5 Mg On 2 Days/ Wk. During the same period patient was treated with VERAPAMIL (View Verapamil Review and Verapamil Label ), MONOPRIL HCL (View Monopril Hcl Review and Monopril Hcl Label ), BETAPACE (View Betapace Review and Betapace Label ), TRAVATAN (View Travatan Review and Travatan Label ), TIMOPTIC (View Timoptic Review and Timoptic Label ).

4828267-6 | International Normalised Ratio Increased
Adverse event was reported on Nov 14, 2005 by a Female patient taking Jantoven (View Usage) (Dosage: 5 Mg Qd) was diagnosed with thrombosis and. Location: UNITED STATES , weighting 150.0 lb, Patient experienced the following unwanted or unexpected effects: international normalised ratio increased. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ), VICODEN (View Vicoden Review and Vicoden Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), DYAZIDE (View Dyazide Review and Dyazide Label ).

4825124-6 | Anaemia, Haematochezia, Rectal Haemorrhage
on Nov 09, 2005 Male patient from UNITED STATES , weighting 244.0 lb, was diagnosed with cerebrovascular accident and was treated with Jantoven (View Usage). Patient had the following side effects: anaemia, haematochezia, rectal haemorrhage. Jantoven dosage: 6mg- 6 Days/wk ; 2mg- 1 Day/wk.

4784722-9 | Ileus, International Normalised Ratio Fluctuation, Prothrombin Time Prolonged
on Sep 29, 2005 Male patient from UNITED STATES , weighting 189.0 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Jantoven (View Usage). After Jantoven was administered, patient had the following side effects: ileus, international normalised ratio fluctuation, prothrombin time prolonged. Jantoven dosage: . During the same period patient was treated with ZANTAC (View Zantac Review and Zantac Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), COLACE (View Colace Review and Colace Label ), LASIX (View Lasix Review and Lasix Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), K DUR 10 (View K-dur 10 Review and K-dur 10 Label ). Patient was hospitalized.

4784684-4 | International Normalised Ratio Fluctuation
Patient was taking Jantoven (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio fluctuation on Sep 29, 2005 from UNITED STATES Additional patient health information: Male patient , weighting 205.0 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?), cerebral thrombosis and. Jantoven dosage: . During the same period patient was treated with CLARITIN (View Claritin Review and Claritin Label ), DESYREL (View Desyrel Review and Desyrel Label ), BUMEX (View Bumex Review and Bumex Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), DULCOLAX (View Dulcolax Review and Dulcolax Label ), PREVACID (View Prevacid Review and Prevacid Label ), CELEBREX (View Celebrex Review and Celebrex Label ).

4778469-2 | Epistaxis
Adverse event was reported on Sep 23, 2005 by a Male patient taking Jantoven (View Usage) (Dosage: 10 Mg Q Hs Except 7.5 Mg 2 Nights Per Week) was diagnosed with atrial flutter and. Location: UNITED STATES , 79 years of age, weighting 185.0 lb, Patient had the following side effects: epistaxis. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), ZOCOR (View Zocor Review and Zocor Label ), NEXIUM (View Nexium Review and Nexium Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

4650358-3 | Contusion, Haemorrhage
on Apr 18, 2005 Female patient from , 90 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Jantoven (View Usage). After Jantoven was administered, patient had the following side effects: contusion, haemorrhage. Jantoven dosage: 4 Mg Qd Po. During the same period patient was treated with WARFARIN SODIUM (4. 5 Mg Qd Po) (View Warfarin Sodium Review and Warfarin Sodium Label ), REQUIP (View Requip Review and Requip Label ), SINEMET (View Sinemet Review and Sinemet Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ). Patient was hospitalized.

4600992-1 | Prothrombin Time Abnormal
on Mar 07, 2005 Male patient from , 52 years of age, was treated with Jantoven (View Usage). Patient experienced the following unwanted or unexpected effects: prothrombin time abnormal. Jantoven dosage: 7.5mg Po.